ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.61
-0.40%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,637.865
0.21%
Brent Oil
72.345
-0.14%
Bitcoin
92,884.95
1.00%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) News

Trinity Biotech (TRIB)

Trinity Biotech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateTimeSourceHeadlineSymbolCompany
15/11/202422:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
15/11/202418:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
15/11/202414:00GlobeNewswire Inc.Trinity Biotech Announces Q3 2024 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
14/11/202422:26Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
07/11/202417:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
07/11/202413:19GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Listing RequirementsNASDAQ:TRIBTrinity Biotech PLC
25/10/202417:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
25/10/202417:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
25/10/202412:45GlobeNewswire Inc.Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureNASDAQ:TRIBTrinity Biotech PLC
25/10/202412:45GlobeNewswire Inc.Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformNASDAQ:TRIBTrinity Biotech PLC
07/10/202414:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
07/10/202412:15GlobeNewswire Inc.Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
02/10/202415:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
30/09/202419:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
25/09/202410:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
24/09/202420:05GlobeNewswire Inc.Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health MarketNASDAQ:TRIBTrinity Biotech PLC
23/09/202412:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
20/09/202421:14Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
19/09/202410:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
18/09/202420:05GlobeNewswire Inc.Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with BayerNASDAQ:TRIBTrinity Biotech PLC
10/09/202414:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
09/09/202420:05GlobeNewswire Inc.Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor TechnologyNASDAQ:TRIBTrinity Biotech PLC
05/09/202417:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
05/09/202414:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
04/09/202415:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
03/09/202413:55GlobeNewswire Inc.Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial OfficerNASDAQ:TRIBTrinity Biotech PLC
29/08/202410:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
28/08/202421:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
27/08/202416:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
26/08/202420:05GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 SalesNASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Your Recent History

LSE
GDR
Genedrive
LSE
VAST
Vast Resources
LSE
SCLP
Scancell
LSE
BARC
Barclays
LSE
UPS
LSE
SLP
Sylvania Platinum
LSE
WTB
Whitbread
LSE
RIO
Rio Tinto
LSE
GKP
Gulf Keystone Petroleum
LSE
POLX
Polarean Imaging
LSE
NICL
Nichols
LSE
PANR
Pantheon Resources
LSE
BA.
Bae Systems
LSE
CAV
Cavendish Financial
LSE
AEP
Anglo-eastern Plantations
LSE
EDEN
Eden Research
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06